247 related articles for article (PubMed ID: 18434247)
21. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy.
Ozkurt Z; Kiki I; Erol S; Erdem F; Yilmaz N; Parlak M; Gundogdu M; Tasyaran MA
J Infect; 2006 Mar; 52(3):207-15. PubMed ID: 15953646
[TBL] [Abstract][Full Text] [Related]
22. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
Mardani M; Jahromi MK; Naieni KH; Zeinali M
Clin Infect Dis; 2003 Jun; 36(12):1613-8. PubMed ID: 12802764
[TBL] [Abstract][Full Text] [Related]
23. Ocular findings in patients with Crimean-Congo hemorrhagic fever.
Engin A; Erdogan H; Ozec AV; Elaldi N; Toker MI; Bakir M; Dokmetas I; Arici MK
Am J Ophthalmol; 2009 Apr; 147(4):634-638.e1. PubMed ID: 19195635
[TBL] [Abstract][Full Text] [Related]
24. Does electrocardiography at admission predict outcome in Crimean -Congo hemorrhagic fever?
Yilmaz MB; Engin A; Bektasoglu G; Zorlu A; Ege MR; Bakir M; Dokmetas I
J Vector Borne Dis; 2011 Sep; 48(3):150-4. PubMed ID: 21946714
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.
Elaldi N; Bodur H; Ascioglu S; Celikbas A; Ozkurt Z; Vahaboglu H; Leblebicioglu H; Yilmaz N; Engin A; Sencan M; Aydin K; Dokmetas I; Cevik MA; Dokuzoguz B; Tasyaran MA; Ozturk R; Bakir M; Uzun R
J Infect; 2009 Mar; 58(3):238-44. PubMed ID: 19246100
[TBL] [Abstract][Full Text] [Related]
26. Prompt administration of Crimean-Congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR.
Kubar A; Haciomeroglu M; Ozkul A; Bagriacik U; Akinci E; Sener K; Bodur H
Jpn J Infect Dis; 2011; 64(5):439-43. PubMed ID: 21937830
[TBL] [Abstract][Full Text] [Related]
27. Clinical investigation of the transient evoked otoacoustic emission test in Crimean-Congo hemorrhagic fever.
Engin A; Yildirim A; Kunt T; Bakir M; Dokmetas I; Ozdemir L
Int J Infect Dis; 2008 Mar; 12(2):162-5. PubMed ID: 17714968
[TBL] [Abstract][Full Text] [Related]
28. The frequency of self-reported allergic diseases in patients with crimean-congo haemorrhagic fever.
Abadoglu O; Engin A
Allergol Immunopathol (Madr); 2009; 37(5):234-8. PubMed ID: 19775796
[TBL] [Abstract][Full Text] [Related]
29. The diagnostic and prognostic significance of SCUBE1 levels in Crimean-Congo hemorrhagic fever.
Menteşe A; Yilmaz G; Sümer A; Arslan M; Karahan SC; Köksal I
Int J Infect Dis; 2013 Nov; 17(11):e1042-5. PubMed ID: 23632301
[TBL] [Abstract][Full Text] [Related]
30. First Crimean-Congo hemorrhagic fever outbreak in India.
Patel AK; Patel KK; Mehta M; Parikh TM; Toshniwal H; Patel K
J Assoc Physicians India; 2011 Sep; 59():585-9. PubMed ID: 22334974
[TBL] [Abstract][Full Text] [Related]
31. Serum nitric oxide levels in patients with Crimean-Congo haemorrhagic fever.
Tütüncü EE; Gurbuz Y; Ozturk B; Kuscu F; Sencan I
Scand J Infect Dis; 2010 May; 42(5):385-8. PubMed ID: 20095935
[TBL] [Abstract][Full Text] [Related]
32. The lack of Crimean-Congo hemorrhagic fever virus antibodies in healthcare workers in an endemic region.
Ergonul O; Zeller H; Celikbas A; Dokuzoguz B
Int J Infect Dis; 2007 Jan; 11(1):48-51. PubMed ID: 16600655
[TBL] [Abstract][Full Text] [Related]
33. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever.
Cevik MA; Erbay A; Bodur H; Eren SS; Akinci E; Sener K; Ongürü P; Kubar A
Clin Infect Dis; 2007 Oct; 45(7):e96-100. PubMed ID: 17806044
[TBL] [Abstract][Full Text] [Related]
34. A case of nosocomial transmission of Crimean-Congo hemorrhagic fever from patient to patient.
Gürbüz Y; Sencan I; Oztürk B; Tütüncü E
Int J Infect Dis; 2009 May; 13(3):e105-7. PubMed ID: 18948048
[TBL] [Abstract][Full Text] [Related]
35. [Crimean-Congo Hemorrhagic Fever].
Güneş T
Mikrobiyol Bul; 2006 Jul; 40(3):279-87. PubMed ID: 17001860
[TBL] [Abstract][Full Text] [Related]
36. Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: Viral load.
Hasanoglu I; Guner R; Carhan A; Kocak Tufan Z; Yagci-Caglayik D; Guven T; Yilmaz GR; Tasyaran MA
J Clin Virol; 2016 Feb; 75():42-6. PubMed ID: 26780111
[TBL] [Abstract][Full Text] [Related]
37. Genetic analysis of the M RNA segment of Crimean-Congo hemorrhagic fever virus strains in Turkey.
Ozdarendeli A; Aydin K; Tonbak S; Aktas M; Altay K; Koksal I; Bolat Y; Dumanli N; Kalkan A
Arch Virol; 2008; 153(1):37-44. PubMed ID: 17955162
[TBL] [Abstract][Full Text] [Related]
38. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007.
Yilmaz GR; Buzgan T; Irmak H; Safran A; Uzun R; Cevik MA; Torunoglu MA
Int J Infect Dis; 2009 May; 13(3):380-6. PubMed ID: 18986819
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever.
Ergonul O; Tuncbilek S; Baykam N; Celikbas A; Dokuzoguz B
J Infect Dis; 2006 Apr; 193(7):941-4. PubMed ID: 16518755
[TBL] [Abstract][Full Text] [Related]
40. Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions.
Mardani M; Rahnavardi M; Rajaeinejad M; Naini KH; Chinikar S; Pourmalek F; Rostami M; Shahri MH
Am J Trop Med Hyg; 2007 Mar; 76(3):443-5. PubMed ID: 17360865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
